- ￥1008 - 1668
- abinScience
- China
- VK564074
- 2026年04月02日
- Rabbit
- Porcine epidemic diarrhea virus
企业认证
相关产品推荐更多 >
Anti-Human ACVR1C Antibody (SAA1706), 抗人ACVR1C抗体 (SAA1706)
￥1176
Anti-K48-linked Polyubiquitin Antibody (SAA0329), 抗K48-linkedPolyubiquitin抗体 (SAA0329)
￥1338
Anti-HPeV-1 VP3 Polyclonal Antibody, 抗HPeV-1VP3多克隆抗体
￥1668
Anti-Human CD154/CD40LG/TNFSF5 Antibody (5C8), PE, 抗人CD154/CD40LG/TNFSF5抗体 (5C8), PE标记
询价
Anti-Human EPHA2 Antibody (SAA2279), 抗人EPHA2抗体 (SAA2279)
￥1668
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Porcine epidemic diarrhea virus
- 保质期：
1 year
- 抗原来源：
Rabbit
- 目录编号：
VK564074
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Rabbit
- 靶点：
E2, Peplomer protein, S, S glycoprotein, Spike glycoprotein
- 规格：
50ug/100ug
| 规格： | 50ug | 产品价格： | ￥1008.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥1668.0 |
| Product name | Anti-PEDV Spike Glycoprotein S2 Polyclonal Antibody |
|---|---|
| Catalog No. | VK564074 |
| Host species | Rabbit |
| Species reactivity | Porcine epidemic diarrhea virus |
| Immunogen | E. coli - derived recombinant PEDV Spike Glycoprotein S2 (Gly777-Val1120). |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA, IHC, WB |
| Target | E2, Peplomer protein, S, S glycoprotein, Spike glycoprotein |
| Purification | Purified by antigen affinity column. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | Q91AV1 |
| Stability and Storage | \ |
| Clone ID | \ |
| Note | For research use only. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product quality.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. To study the maturation pathway of the S glycoprotein of the severe acute respiratory
coronavirus, porcine hemagglutinating encephalomyelitis virus, equine coronavirus, bovine coronavirus (BCoV), and wild-ruminant coronaviruses. The presence of a hemagglutinin-esterase (HE) surface glycoprotein in addition to the viral spike protein
全球首次！分离的新冠病毒中和抗体，还可同时抗 SARS 病毒
抗原表位，为预防和治疗新型冠状病毒肺炎 COVID- 19 提供了可能。图片来源：bioRxiv通常，冠状病毒中和抗体主要靶向介导进入宿主细胞的病毒表面三聚体刺突糖蛋白（Spike Glycoproteins，S 蛋白）。S 蛋白具有介导细胞附着的两个功能亚基：负责受体识别的 S1 亚基（存在四个核心结构域 S1 A/B/C/D）以及促使病毒与细胞膜融合的 S2 亚基。强大的中和抗体通常会靶向 S1 中的受体相互作用位点，从而使受体相互作用失效。之前的研究表明，SARS-CoV- 2 和 SARS-CoV
技术资料暂无技术资料 索取技术资料
